Literature DB >> 17565318

Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.

Todd J Grazia1, Robert J Plenter, An N Doan, Brian P Kelly, Sarah M Weber, Jonathan S Kurche, Susan O Cushing, Ronald G Gill, Biagio A Pietra.   

Abstract

BACKGROUND: Acute cardiac allograft rejection requires host, but not donor, expression of B7-1/B7-2 costimulatory molecules. However, acute cardiac rejection requires direct antigen presentation by donor-derived antigen presenting cells to CD4 T-cells and does not require indirect antigen presentation to CD4 T-cells. Given this discrepancy in the literature and that the consequence of allograft exposure in B7-deficient mice is unknown; the goal of the study was to examine the antidonor status of allografted B7-1/B7-2-deficient hosts.
METHODS: C57Bl/6 B7-1/B7-2-/- mice were grafted with heterotopic BALB/c hearts. Recipients bearing long-term surviving allografts were used to examine the status of antidonor reactivity in vitro and in vivo. Tolerance was examined in vivo through adoptive transfer of splenocytes from graft-bearing animals to secondary immune-deficient Rag-1-/- hosts bearing donor-type or third-party cardiac allografts and by regulatory T-cell depletion with anti-CD25 antibody.
RESULTS: When transferred to B7-replete Rag-1-/- recipients, cells from naïve B7-1/B7-2-/- mice readily initiated cardiac allograft rejection. However, splenocytes transferred from long-term allograft acceptor B7-1/B7-2-/- hosts failed to reject donor-type hearts but acutely rejected third-party allografts. In addition, such cells did not reject (donorxthird-party) F1 allografts. Finally, in vivo depletion of regulatory T-cells did not prevent long-term acceptance.
CONCLUSIONS: Results demonstrate that B7-deficient T-cells are capable of acute cardiac allograft rejection in a B7-replete environment. Importantly, results also show that B7-deficient hosts do not simply ignore cardiac allografts, but rather spontaneously develop transferable, donor-specific tolerance and linked suppression in vivo. Interestingly, this tolerant state does not require endogenous CD4+CD25+ regulatory T-cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565318      PMCID: PMC4427242          DOI: 10.1097/01.tp.0000265482.88936.b1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  40 in total

1.  T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties.

Authors:  Guido Ferlazzo; Claudia Semino; Maurizio Meta; Francesco Procopio; Barbara Morandi; Giovanni Melioli
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

2.  A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.

Authors:  Todd J Grazia; Biagio A Pietra; Zachary A Johnson; Brian P Kelly; Robert J Plenter; Ronald G Gill
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

3.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

Authors:  Xuguang Tai; Michelle Cowan; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

4.  T cell suppression in transplantation tolerance through linked recognition.

Authors:  J D Davies; L Y Leong; A Mellor; S P Cobbold; H Waldmann
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

5.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation.

Authors:  F Borriello; M P Sethna; S D Boyd; A N Schweitzer; E A Tivol; D Jacoby; T B Strom; E M Simpson; G J Freeman; A H Sharpe
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

6.  CD4+ but not CD8+ cells are essential for allorejection.

Authors:  N R Krieger; D P Yin; C G Fathman
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

8.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 9.  Costimulation and its role in organ transplantation.

Authors:  J A Bluestone
Journal:  Clin Transplant       Date:  1996-02       Impact factor: 2.863

10.  Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody.

Authors:  C G Orosz; E Wakely; S D Bergese; A M VanBuskirk; R M Ferguson; D Mullet; G Apseloff; N Gerber
Journal:  Transplantation       Date:  1996-03-15       Impact factor: 4.939

View more
  3 in total

1.  Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells.

Authors:  T J Grazia; R J Plenter; H M Lepper; F Victorino; S D Miyamoto; J T Crossno; B A Pietra; R G Gill; M R Zamora
Journal:  Am J Transplant       Date:  2010-11-29       Impact factor: 8.086

2.  Circulating cytokine portraits can differentiate between allograft rejection and pulmonary infection in cardiac transplant rats.

Authors:  Hao Chen; Feng Li; Yanxia Zhan; Weiyong Yu; Chen Lu; Yunfeng Cheng; Yunqing Mei
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-22

3.  Anti-LFA-1 induces CD8 T-cell dependent allograft tolerance and augments suppressor phenotype CD8 cells.

Authors:  Robert J Plenter; Todd J Grazia; Marilyne G Coulombe; Michelle K Nelsen; Christine M Lin; K Scott Beard; Tinalyn M Kupfer; Martin R Zamora; Ronald G Gill; Biagio A Pietra
Journal:  Cell Immunol       Date:  2018-08-07       Impact factor: 4.868

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.